OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.17 Cr | ₹2.91 Cr | - | - | ₹1.20 Cr |
What is the latest Contingent Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹0.17 Cr |
| Mar2025 | ₹2.91 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | ₹1.20 Cr |
How is Contingent Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.17 Cr | -94.26 | |
| Mar2025 | ₹2.91 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹1.20 Cr | - | |
Compare Contingent Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹251.2 Cr | 31% | 40.5% | -35.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 31% |
40.5% |
-35.4% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses